|
|
|
|
LEADER |
00000cam a2200000 a 4500 |
001 |
SCIDIR_ocn162128810 |
003 |
OCoLC |
005 |
20231117014741.0 |
006 |
m o d |
007 |
cr cn||||||||| |
008 |
070802s1997 caua ob 001 0 eng d |
040 |
|
|
|a OPELS
|b eng
|e pn
|c OPELS
|d OPELS
|d OCLCQ
|d IDEBK
|d OCLCQ
|d N$T
|d YDXCP
|d OCLCE
|d E7B
|d OCLCQ
|d OCLCA
|d OCLCO
|d OCLCF
|d CHVBK
|d DEBSZ
|d OCLCQ
|d UAB
|d OCLCQ
|d CASUM
|d OCLCA
|d STF
|d D6H
|d OCLCO
|d OCLCQ
|d AU@
|d OCLCA
|d S2H
|d OCLCO
|d OCLCQ
|d OCLCO
|d INARC
|d COM
|d OCLCO
|d OCLCQ
|d OCLCO
|
016 |
7 |
|
|a 573155305
|2 DE-101
|
019 |
|
|
|a 180765604
|a 605746798
|a 608130409
|a 742284742
|a 987773982
|a 1011199547
|a 1035656625
|a 1058040960
|a 1086559854
|a 1280893759
|
020 |
|
|
|a 9780125468206
|
020 |
|
|
|a 0125468202
|
020 |
|
|
|a 9780080531342
|q (electronic bk.)
|
020 |
|
|
|a 0080531342
|q (electronic bk.)
|
035 |
|
|
|a (OCoLC)162128810
|z (OCoLC)180765604
|z (OCoLC)605746798
|z (OCoLC)608130409
|z (OCoLC)742284742
|z (OCoLC)987773982
|z (OCoLC)1011199547
|z (OCoLC)1035656625
|z (OCoLC)1058040960
|z (OCoLC)1086559854
|z (OCoLC)1280893759
|
042 |
|
|
|a dlr
|
050 |
|
4 |
|a QP364.7
|b .E93 1997
|
060 |
|
4 |
|a 1997 C-952
|
060 |
|
4 |
|a QV 126
|b E97 1997
|
072 |
|
7 |
|a MJN
|2 bicssc
|
072 |
|
7 |
|a MED
|x 057000
|2 bisacsh
|
072 |
|
7 |
|a PSY
|x 020000
|2 bisacsh
|
082 |
0 |
4 |
|a 612.825
|2 22
|
245 |
0 |
0 |
|a Excitatory amino acids :
|b clinical results with antagonists /
|c edited by P.L. Herrling.
|
260 |
|
|
|a San Diego :
|b Academic Press,
|c �1997.
|
300 |
|
|
|a 1 online resource (xii, 156 pages) :
|b illustrations
|
336 |
|
|
|a text
|b txt
|2 rdacontent
|
337 |
|
|
|a computer
|b c
|2 rdamedia
|
338 |
|
|
|a online resource
|b cr
|2 rdacarrier
|
520 |
|
|
|a Glutamate is the major excitatory neurotransmitter in the brain and dysfunction of glutamate transmission is the likely cause of a variety of diseases including neurodegeneration following cerebral ischemia, Huntington's chorea, amyotrophic lateral sclerosis, epilepsy, spasticity, emesis, chronic pain, and schizophrenia. Excitatory amino acid receptor agonists and antagonists are therefore of major interest as potential drugs for central nervous system disorders. Excitatory Amino Acids is the first book entirely dedicated to the results of human testing of modulators of excitatory amino acid neurotransmitters. Features include: * Coverage of the field of excitatory amino acids from synaptic function to preclinical and clinical pharmacology * Description of the development of NMDA (Nmethyl-d-aspartate) and non-NMDA antagonists * Reports of potential drugs in early and late clinical stages of development.
|
505 |
0 |
|
|a M. Schmutz, A. Arthur, H. Faleck, G. Karlsson, A. Kotake, L. Landwicki, L. LaRue, S. Markabi, D. Murphy, M. Powell, and D. Sauer, Selfotel. -- P. Herrling et al., D-CPPene (SDZ EAA-494) A Competitive NMDA Antagonist: Pharmacology and Results in Humans. -- J.D. Kristensen, Intrathecal Administration of a Competitive NMDA Receptor Antagonist for Pain Treatment. -- A.G. Knapp, L.I. Matthews, and E.R. Gamzu, Clinical Experience with the NMDA Ion-Channel Blocker, Aptiganel Hydrochloride (CEROSTAT). -- M.-L. Maccecchini, Development of ACPC: A Partial Agonist of the Glycine Site on the NMDA Receptor. -- Carter et al., Ifenprodil and Eliprodil: Neuroprotective NMDA Receptor Antagonists and Calcium Channel Blockers. -- D. Lodge and D.D. Schoepp, 3S, 8aR-6-[2-(1(2)H-tetrazole-5-y)ethyl] Decahydroisoquinoline-3-carboxylic Acid (LY293558) and Its Racemate (LY215490): A Selective and Competitive AMPA/Kainate Receptor Agonist. -- L. Nordholm, M. Sheardown, and T. Honore, The NBQX Story. -- E. Louvel, Riluzole in Amytrophic Lateral Sclerosis. -- G.C. Plamer and J.B. Hutchinson, Preclinical and Clinical Aspects of Remacemide Hydrochloride.
|
504 |
|
|
|a Includes bibliographical references (pages 129-152) and index.
|
588 |
0 |
|
|a Print version record.
|
506 |
|
|
|3 Use copy
|f Restrictions unspecified
|2 star
|5 MiAaHDL
|
533 |
|
|
|a Electronic reproduction.
|b [Place of publication not identified] :
|c HathiTrust Digital Library,
|d 2010.
|5 MiAaHDL
|
538 |
|
|
|a Master and use copy. Digital master created according to Benchmark for Faithful Digital Reproductions of Monographs and Serials, Version 1. Digital Library Federation, December 2002.
|u http://purl.oclc.org/DLF/benchrepro0212
|5 MiAaHDL
|
583 |
1 |
|
|a digitized
|c 2010
|h HathiTrust Digital Library
|l committed to preserve
|2 pda
|5 MiAaHDL
|
650 |
|
0 |
|a Excitatory amino acids.
|
650 |
|
0 |
|a Excitatory amino acids
|x Pathophysiology.
|
650 |
|
0 |
|a Methyl aspartate
|x Receptors.
|
650 |
|
2 |
|a Excitatory Amino Acids
|x antagonists & inhibitors
|0 (DNLM)D018846Q000037
|
650 |
|
2 |
|a Excitatory Amino Acids
|x pharmacology
|0 (DNLM)D018846Q000494
|
650 |
|
2 |
|a Excitatory Amino Acids
|0 (DNLM)D018846
|
650 |
|
6 |
|a Acides amin�es excitateurs.
|0 (CaQQLa)201-0218584
|
650 |
|
6 |
|a Acides amin�es excitateurs
|0 (CaQQLa)201-0218584
|x Physiopathologie.
|0 (CaQQLa)201-0379296
|
650 |
|
6 |
|a M�ethylaspartate
|0 (CaQQLa)201-0250087
|x R�ecepteurs.
|0 (CaQQLa)201-0375415
|
650 |
|
7 |
|a MEDICAL
|x Neuroscience.
|2 bisacsh
|
650 |
|
7 |
|a PSYCHOLOGY
|x Neuropsychology.
|2 bisacsh
|
650 |
|
7 |
|a Excitatory amino acids
|2 fast
|0 (OCoLC)fst00917715
|
650 |
|
7 |
|a Excitatory amino acids
|x Pathophysiology
|2 fast
|0 (OCoLC)fst00917716
|
650 |
|
7 |
|a Methyl aspartate
|x Receptors
|2 fast
|0 (OCoLC)fst01018742
|
700 |
1 |
|
|a Herrling, P. L.
|
776 |
0 |
8 |
|i Print version:
|t Excitatory amino acids.
|d San Diego : Academic Press, �1997
|z 0125468202
|z 9780125468206
|w (OCoLC)36568957
|
856 |
4 |
0 |
|u https://sciencedirect.uam.elogim.com/science/book/9780125468206
|z Texto completo
|